For the Inventor, By the Inventor

Enter assignee name

Chestnut Ridge, NY, United States of America

Par Pharmaceutical, Inc.

USPTO Granted Patents = 43

% Expired Patents = 16.3

CIPO Patents = 2

Trademarks = 3

Forward Citations = 241

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Vinayagam Kannan (23 out of 23 patents)

Matthew Kenney (20 out of 22 patents)

Suketu Sanghvi (19 out of 30 patents)

4. Sunil Vandse (17 out of 20 patents)

5. Anthony P Sileno (7 out of 18 patents)

6. Zenaida Go (7 out of 11 patents)

7. Steven C Quay (7 out of 94 patents)

8. Satish Shamlal Patil (5 out of 5 patents)

9. Peter C Aprile (4 out of 6 patents)

10. Robert Ruemer (4 out of 4 patents)

11. Narayan Ragunathan (4 out of 7 patents)

12. Robert A Femia (4 out of 8 patents)

13. Mohankumar Lakshmanan (4 out of 4 patents)

14. Selvakumar Viruthagiri (4 out of 4 patents)

15. Somasundaram Muthuramalingam (4 out of 4 patents)

Core Competencies:

Vasopressin Formulations

Epinephrine Formulations

Cyanocobalamin

Intranasal Delivery

Nasal Calcitonin

Sugammadex

Hypotension Treatment

Chlorobutanol

Vareniciline

Flecainide Precursors

Low Viscosity

43 patents: Sort by Forward Citations

1. 12186362 - Vasopressin formulations for use in treatment of hypotension (2025-01-07),

2. 11872234 - Vareniciline compound and process of manufacture thereof (2024-01-16),

3. 11779587 - Vareniciline compound and process of manufacture thereof (2023-10-10),

4. 11717524 - Varenicline compound and process of manufacture thereof (2023-08-08),

5. 11602537 - Varenicline compound and process of manufacture thereof (2023-03-14),

6. 11337938 - Epinephrine formulations (2022-05-24),

7. 11207372 - Vasopressin formulations for use in treatment of hypotension (2021-12-28),

8. 11135265 - Vasopressin formulations for use in treatment of hypotension (2021-10-05),

9. 11097023 - Pre-filled syringe containing sugammadex (2021-08-24),

10. 10920278 - Method to treat hypotension using vasopressin in certain genotypes (2021-02-16),

11. 10844435 - Method to treat hypotension using vasopressin in certain genotypes (2020-11-24),

12. 10624864 - Epinephrine formulations (2020-04-21),

13. 10130592 - Epinephrine formulations (2018-11-20),

14. 10010575 - Vasopressin formulations for use in treatment of hypotension (2018-07-03),

15. 9993520 - Vasopressin formulations for use in treatment of hypotension (2018-06-12),

Company Overview

Par Pharmaceutical, Inc. is a prominent player in the pharmaceutical industry, headquartered in Chestnut Ridge, NY. The company specializes in the development and manufacturing of a diverse range of formulations, including vasopressin and epinephrine, as well as innovative delivery systems such as intranasal and pre-filled syringe technologies. Par's expertise extends to compounds like varenicline and sugammadex, positioning it as a key contributor to advancements in therapeutic solutions and patient care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

43 Patents

#2 in Chestnut Ridge, NY

#497 in New York

#8,099 in US

#16,040 in the World

Chestnut Ridge, NY, United States of America

Par Pharmaceutical, Inc.

Forward Citations = 241

32 inventors:

Vinayagam Kannan (23 out of 23 patents)

Matthew Kenney (20 out of 22 patents)

Suketu Sanghvi (19 out of 30 patents)

4. Sunil Vandse (17 out of 20 patents)

5. Anthony P Sileno (7 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Par Pharmaceutical, Inc.. Retrieved from https://idiyas.com/company/par-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…